Patents-Review.com
ClassID:

110842 ⎘

C12N2760/16251 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus B, i.e. influenza B virus Methods of production or purification of viral material

Sub-classes:
Recent Application in this class:
#1
20260041756
2026-02-12

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

 #2
20240216500
2024-07-04

RESPIRATORY VIRUS COMBINATION VACCINES

 #3
20240076320
2024-03-07

DOWNSTREAM PROCESS FOR PURIFICATION OF VIRAL PROTEINS WITH HYDROPHOBIC MEMBRANE DOMAIN FOR USE IN VACCINE COMPOSITIONS

 #4
20220387579
2022-12-08

Vaccine compositions having improved stability and immunogenicity

 #5
20220202926
2022-06-30

INFLUENZA B VIRUS REPLICATION FOR VACCINE DEVELOPMENT

 #6
20220160863
2022-05-26

HIGH GROWTH INFLUENZA VIRUS

 #7
20220145317
2022-05-12

INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

 #8
20220003767
2022-01-06

METHOD

 #9
20210101458
2021-04-08

Fabric top for a convertible vehicle and convertible vehicle

 #10
20210008194
2021-01-14

MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production

 #11
20200263142
2020-08-20

Generation of infectious influenza viruses from virus-like particles

 #12
20200255849
2020-08-13

Influenza virus-like particle production in plants

 #13
20200215184
2020-07-09

Influenza virus reassortment

 #14
20200215183
2020-07-09

Production of flu vaccine in

#15
20200155665
2020-05-21

Vaccine compositions

 #16
20200101151
2020-04-02

Vaccine compositions having improved stability and immunogenicity

 #17
20200040040
2020-02-06

Compositions and methods to increase production

 #18
20190382854
2019-12-19

GENERIC ASSAYS FOR DETECTION OF INFLUENZA VIRUSES

 #19
20190352615
2019-11-21

METHOD FOR PURIFYING VIRUS

 #20
20190062713
2019-02-28

Highly efficient influenza matrix (M1) proteins

 #21
20180339037
2018-11-29

Oil-in-water emulsion influenza vaccine

 #22
20180339036
2018-11-29

Method for the production of stabile vaccines

 #23
20180311337
2018-11-01

MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production

 #24
20180299444
2018-10-18

SAMPLE QUANTIFICATION BY DISC CENTRIFUGATION

 #25
20180236058
2018-08-23

Reverse genetics systems

 #26
20180133308
2018-05-17

Vaccine compositions having improved stability and immunogenicity

 #27
20170369853
2017-12-28

FORMULATION OF SUGAR SOLUTIONS FOR CONTINUOUS ULTRACENTRIFUGATION FOR VIRUS PURIFICATION

 #28
20170258888
2017-09-14

Influenza B virus replication for vaccine development

 #29
20170253861
2017-09-07

Highly efficient influenza matrix (M1) proteins

 #30
20170246290
2017-08-31

Oil-in-water emulsion influenza vaccine

 #31
20170202948
2017-07-20

Vaccine compositions having improved stability and immunogenicity

 #32
20170058265
2017-03-02

Generation of infectious influenza viruses from virus-like particles

 #33
20170044216
2017-02-16

COMPOSITIONS AND METHODS TO INCREASE PRODUCTION

 #34
20160273057
2016-09-22

GENERIC ASSAYS FOR DETECTION OF INFLUENZA VIRUSES

 #35
20160208220
2016-07-21

Method of viral purification

 #36
20160199480
2016-07-14

Method for preparing virosomes

 #37
20160129106
2016-05-12

Method for preparing virosomes

 #38
20160122777
2016-05-05

Influenza virus-like particle production in plants

 #39
20160108367
2016-04-21

MDCK-derived cell strain suspension-cultured in protein-free medium and method for proliferating virus using cell strain

 #40
20160060603
2016-03-03

Formulation of sugar solutions for continuous ultracentrifugation for virus purification

 #41
20160051660
2016-02-25

METHODS OF PRODUCING INFLUENZA VACCINE COMPOSITIONS

 #42
20160038585
2016-02-11

Influenza virus reassortment

 #43
20150353900
2015-12-10

Influenza virus reassortment

 #44
20150322411
2015-11-12

Method of replicating viruses in suspension cultures of dog kidney cells

 #45
20150307849
2015-10-29

Highly efficient influenza matrix (M1) proteins

 #46
20150247128
2015-09-03

MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells

 #47
20150191703
2015-07-09

Production of infectious influenza viruses

 #48
20150166967
2015-06-18

Recombinant influenza vectors with tandem transcription units

 #49
20150104480
2015-04-16

Increasing virus-like particle yield in plants

 #50
20140370494
2014-12-18

Exogenous internal positive control

 #51
20140341948
2014-11-20

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #52
20130189762
2013-07-25

Multi plasmid system for the production of influenza virus

 #53
20130189305
2013-07-25

Methods of producing influenza vaccine compositions

 #54
20130052717
2013-02-28

MDCK cell lines supporting viral growth to high titers and bioreactor process using the same

 #55
20130039938
2013-02-14

Highly efficient influenza matrix (M1) proteins

 #56
20120282294
2012-11-08

Refrigerator-temperature stable influenza vaccine compositions

 #57
20120270321
2012-10-25

Reverse genetics systems

 #58
20120258136
2012-10-11

Methods for cultivating cells, propagating and purifying viruses

 #59
20120258134
2012-10-11

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #60
20120201851
2012-08-09

GENERIC ASSAY FOR DETECTION OF INFLUENZA VIRUSES

 #61
20120196371
2012-08-02

Multi plasmids system for the production of influenza virus

 #62
20120115206
2012-05-10

Non-tumorigenic MDCK cell line for propagating viruses

 #63
20120058145
2012-03-08

METHOD FOR PRODUCING VIRUS FROM CELL CULTURE INVOLVING HOMOGENIZATION

 #64
20120027797
2012-02-02

Preservation of bioactive materials by freeze dried foam

 #65
20120009248
2012-01-12

Preservation of bioactive materials by spray drying

 #66
20110300604
2011-12-08

Recombinant influenza vectors with tandem transcription units

 #67
20110217330
2011-09-08

NOVEL METHOD

 #68
20110191915
2011-08-04

Influenza virus immunizing epitope

 #69
20110150925
2011-06-23

CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES

 #70
20110142863
2011-06-16

FLOW THROUGH PURIFICATION PROCESSES FOR LARGE BIOMOLECULES

 #71
20110097785
2011-04-28

METHOD OF REPLICATING VIRUSES IN SUSPENSION CULTURES OF DOG KIDNEY CELLS

 #72
20100239609
2010-09-23

Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification

 #73
20100239606
2010-09-23

Two-Step Temperature Profile for the Propagation of Viruses

 #74
20100233785
2010-09-16

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

 #75
20100189741
2010-07-29

Oil-in-water emulsion influenza vaccine

 #76
20100173280
2010-07-08

Systems for Detection and Production of Respiratory, Herpes and Enteric Viruses

 #77
20100158942
2010-06-24

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

 #78
20100112669
2010-05-06

Method of purifying influenza virus and removing MDCK cell DNA contaminants

 #79
20100112000
2010-05-06

Non-tumorigenic MDCK cell line for propagating viruses

 #80
20100098725
2010-04-22

Methods for cultivating cells, propagating and purifying viruses

 #81
20100041022
2010-02-18

Assay for the separation and quantification of hemagglutinin antigens

 #82
20100021499
2010-01-28

Cell-based systems for producing influenza vaccines

 #83
20100010199
2010-01-14

MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS

 #84
20100003221
2010-01-07

Medium supplement for virus production

 #85
20090317425
2009-12-24

Refrigerator-temperature stable influenza vaccine compositions

 #86
20090297554
2009-12-03

Multi plasmid system for the production of influenza virus

 #87
20090246225
2009-10-01

Methods of Producing Influenza Vaccine Compositions

 #88
20090208527
2009-08-20

Multi plasmid system for the production of influenza virus

 #89
20090203114
2009-08-13

Methods for the propagation of modified influenza viruses in embryonated eggs

 #90
20090136543
2009-05-28

Influenza vaccine

 #91
20090060950
2009-03-05

Method for producing viral vaccines

 #92
20090053264
2009-02-26

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #93
20080286850
2008-11-20

MDCK CELL LINES SUPPORTING VIRAL GROWTH TO HIGH TITERS AND BIOREACTOR PROCESS USING THE SAME

 #94
20080286307
2008-11-20

Two-step temperature profile for the propagation of viruses

 #95
20080274138
2008-11-06

Formulation of sugar solutions for continuous ultracentrifugation for virus purification

 #96
20080254067
2008-10-16

Process for the Production of an Influenza Vaccine

 #97
20080241244
2008-10-02

Preservation of bioactive materials by freeze dried foam

 #98
20080131514
2008-06-05

Preservation of bioactive materials by spray drying

 #99
20080112972
2008-05-15

Preservation of bioactive materials by freeze dried foam

 #100
20070259334
2007-11-08

Preservation of bioactive materials by spray drying

 #101
20070196387
2007-08-23

Assay for the separation and quantification of hemagglutinin antigens

 #102
20070161085
2007-07-12

Methods of Producing Influenza Vaccine Compositions

 #103
20070141078
2007-06-21

Influenza vaccine

 #104
20070065939
2007-03-22

Systems for detection and production of respiratory, herpes and enteric viruses

 #105
20060188977
2006-08-24

Non-tumorigenic MDCK cell line for propagating viruses

 #106
20060166321
2006-07-27

Recombinant influenza vectors with tandem transcription units

 #107
20060110406
2006-05-25

Refrigerator-temperature stable influenza vaccine compositions

 #108
20060051742
2006-03-09

Assay for the separation and quantification of hemagglutinin antigens

 #109
20050158342
2005-07-21

Multi plasmid system for the production of influenza virus

 #110
20050118140
2005-06-02

Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture

 #111
20050054074
2005-03-10

Methods and interferon deficient substrates for the propagation of viruses